The rise of drug-resistant bacteria infections is one
of the world’s most severe global health issues, estimated to cause
10 million deaths annually by the year 2050. Some of the most
virulent and antibiotic-resistant bacterial pathogens are the
leading cause of life-threatening, hospital-acquired infections,
particularly dangerous for immunocompromised and critically ill
patients. Traditional and continual synthesis of antibiotics will
simply not be able to keep up with bacteria
evolution.